动态病毒整合模式在移植后积极参与BK多重瘤病毒相关疾病的进展
Yuchen Wang1, Susha Yan1, Yanna Liu2
1Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.
概括
结合到宿主DNA中的BK多瘤病毒 (BKPyV) 驱动疾病的进展和瘤发生,为BKPyV相关疾病提供了新的点. 了解病毒融合是监测和治疗的关键.
科学领域:
- 病毒学 病毒学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 乙基多瘤病毒 (BKPyV) 感染是移植后的重大并发症,导致乙基多瘤病毒相关性脏病 (BKVAN) 和相关瘤.
- 关于BKPyV瘤发生的经典理论并不能完全解释因病毒病,DNAemia和病毒病而导致的二次瘤发展.
研究的目的:
- 调查 BKPyV 融合模式在 BKPyV 相关疾病,包括脏病和泌尿腺癌的进展中的作用.
- 阐明BKPyV集成对瘤发生有助于形成的机制,并确定潜在的治疗点.
主要方法:
- 对20名患者的尿液,血液和组织样本进行病毒捕获测序和病理检查.
- 在现场聚合酶连锁反应 (PCR) 用于可视化整合部位和评估基因表达.
- 长期阅读的基因组测序和瘤组织的多组学分析.
主要成果:
- 在早期非癌症阶段观察到BKPyV集成部位,在疾病进展过程中增加了集成强度和依赖微同质介导末端结合 (MMEJ).
- BKPyV集成被证明会破坏宿主基因表达,增加病毒蛋白水平,并激活DNA双链断裂修复通路.
- 奥拉巴里布在缺乏BRCA1/2突变的BCPyV相关瘤器官中表现出剂量依赖的抗瘤活性.
结论:
- 动态的BKPyV整合模式积极参与BKPyV相关疾病的进展.
- BKPyV的整合及其对宿主DNA修复途径的影响,代表了疾病监测和治疗干预的潜在目标.
相关概念视频
Kidney Transplant I: Introduction
29
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
Chronic Kidney Disease II: Clinical Manifestations
32
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
32
Acute Kidney Injury III: Clinical Manifestations
34
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
34
Acute Kidney Injury II: Pathophysiology
33
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
33
Acute Kidney Injury IV: Diagnostic Studies and Prevention
35
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
35
Viral Recombination
23.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K


